| Pharmaceutical active ingredients: |
| Hexobarbital |
| Available forms, composition and doses of Citopan: |
| N / A |
| Citopan medical category: |
| Human:Barbiturate derivativesHypnotics and sedatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05CA16 - Hexobarbital |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Vagi-Hex | Hexetidine | Drossapharm; Commerz Trading International |
| Anso | Hexetidine; Lidocaine Hydrochloride; Pentosan Polysulfate Sodium; Triamcinolone Acetonide | Lacer; CNW Hong Kong; Medreich Kali Macau |
| Nifluril Dental Gel | Hexetidine; Niflumic Acid Glycinamide | Bristol-Myers Squibb; UPSA Laboratoires |
| Oraldene | Hexetidine; Triclosan | Pfizer |
| Barbidorm | Hexobarbital | Unidentified Pharmaceutical Company |
| Cyclonal | Hexobarbital | Unidentified Pharmaceutical Company |
| Cyclopan | Hexobarbital | Unidentified Pharmaceutical Company |
| Enhexymal | Hexobarbital | Unidentified Pharmaceutical Company |
| Enhexymalum | Hexobarbital | Unidentified Pharmaceutical Company |
| Evipal | Hexobarbital | Unidentified Pharmaceutical Company |